Page 387 - ACCCN's Critical Care Nursing
P. 387

364  P R I N C I P L E S   A N D   P R A C T I C E   O F   C R I T I C A L   C A R E

         COLLABORATIVE PRACTICE                               patient–ventilator  synchrony,  especially  when  non-
         The key principles of management are treatment of the   conventional  modes  of  ventilation  are  used.  Improve-
         precipitating cause and providing supportive care during   ments in oxygenation are usually observed and may be
         the period of acute respiratory failure. 6,45  Mortality rates   attributed  to  reduction  in  oxygen  consumption  and
         from ARDS have decreased over time; this is not attrib-  improved  chest  wall  compliance.  The  use  of  NMBAs,
         uted  solely  to  the  use  of  low  tidal  volume  ventilation   however,  is  also  associated  with  an  increased  risk  of
         promoted  by  the  ARDS  Network  group,  but  to  other   myopathy,  so  any  benefits  gained  should  be  weighed
                                                                                51
                              44
         advances in critical care.  Specific strategies include cau-  against known risks.
         tious fluid management, adequate nutrition, prevention   Inhaled  nitric  oxide  (iNO)  therapy  may  be  used  to
         of ventilator-associated pneumonia, prophylaxis for deep   improve  oxygenation  through  selective  vasodilation  of
         venous thrombosis and gastric ulcers, weaning of seda-  the pulmonary blood vessels, promoting improvement in
         tion and mechanical ventilation as early as possible, and   ventilation–perfusion matching. Despite the lack of evi-
         physiotherapy  and  rehabilitation  (similar  to  ARF  man-  dence regarding its effectiveness in improving outcomes
         agement).  Management  involves  a  coordinated  collab-  of patients with ARDS, its use is reasonably widespread.
         orative approach including supportive ventilation, patient   Improvement in oxygenation should be observed within
         positioning and medication administration.           the first hour of treatment to support its ongoing use.
                                                                                                              51
                                                              Some groups have reported the use of iNO to be harmful
         Ventilation Strategies                               and  recommend  that  it  not  be  used,  given  the  lack  of
                                                                                                      52
         The key focus of ventilation in ARDS is the prevention of   evidence demonstrating reduction in mortality. A similar
         refractory  hypoxaemia  rather  than  reversing  it  after  it   effect,  in  terms  of  pulmonary  vasodilation,  has  been
         develops. The use of small tidal volumes and adequate   achieved  using  inhaled  prostacyclines  and  this  remains
         levels of PEEP, along with careful attention to fluid status   under investigation as an alternative therapy. 51
         and  patient–ventilator  synchrony,  may  be  sufficient  to   A number of medications are currently being investigated
         maintain oxygenation at an appropriate level while mini-  to  treat  ARDS  in  acute  and  subacute  exudative  phases.
         mising further damage from barotrauma and nosocomial   These include agents that target the disrupted surfactant
         pneumonia. 6,47  The use of rescue therapies is controversial   system  (exogenous  surfactant  therapy),  oxidative  stress
         as none to date have reduced mortality when studied in   and  antioxidant  activity  (antioxidants),  neutrophil
         large heterogeneous populations of patients with ARDS.   recruitment  and  activation,  expression  and  release  of
         Some therapies however demonstrated improved oxygen-  inflammatory  mediators  (corticosteroids),  activation  of
         ation, which may be an important goal in many patients   the coagulation cascade (immunomodulating agents and
         who  experience  severe  hypoxaemia.  The  key  focus  of   statins),  and  microvascular  injury  and  leak  (beta 2 -
         rescue ventilatory strategies is alveolar recruitment, includ-  agonists).  The use of low-dose corticosteroids has been
                                                                       53
         ing higher levels of PEEP, use of airway pressure release   associated  with  improved  outcomes  for  patients  with
         ventilation (APRV), high-frequency oscillatory ventilation   ARDS,   although  its  use  remains  controversial  and
                                                                    54
         (HFOV)  and  high-frequency  percussive  ventilation   further investigation is recommended.
         (HFPC) (see Chapter 15). If hypoxaemia is severe, extra-
         corporeal life support may also be considered. As there is
         no evidence to support the use of one strategy over another,   SPECIAL CONSIDERATIONS
         the choice of therapy is often based on equipment avail-  ALI and ARDS occur in pregnancy usually as a result of
         ability and clinician expertise. An evidence based approach   aspiration pneumonitis, sepsis or pneumonia. Manage-
         is  likely  to  involve  lung-protective  ventilation  (volume   ment of ventilation is similar to the non-pregnant patient,
         and pressure limitation with modest PEEP) requiring per-  although  consideration  of  the  impact  on  the  fetus  is
         missive hypercapnia and permissive hypoxaemia. 49    important in medication usage and ventilatory manage-
                                                              ment.  Elderly patients who develop ARDS are likely to
                                                                   6
         Prone Positioning                                    experience  an  increased  severity  of  disease,  yet  have  a
         Use  of  prone  positioning  in  patients  with  ARDS  was   mortality  rate  comparable  to  other  patients.  Develop-
         described almost 30 years ago as a means of improving   ment of other organ dysfunction depends on the presence
         oxygenation.  This  improvement  is  largely  due  to  the   of  chronic  conditions  such  as  renal  and  cardiovascular
         effect that the prone position has on chest wall and lung   diseases. 55
         compliance. The result is a more homogenous ventilation
         of the lungs and improved ventilation–perfusion match-  ASTHMA AND CHRONIC
         ing.   Investigation  into  the  effectiveness  of  this  as  a   OBSTRUCTIVE PULMONARY DISEASE
             6
         therapy in ARDS has noted improvement in oxygenation,
         but  no  corresponding  improvement  in  mortality.  It  is   Asthma is defined as a respiratory condition where airflow
         therefore recommended as a rescue therapy for the patient   limitation may be fully or partially reversible either spon-
         at risk of death from hypoxia, rather than as a routine   taneously  or  with  treatment. 56-58   COPD  is  a  respiratory
         treatment.  See Chapter 15 for further discussion.   condition  defined  by  a  largely  fixed  airflow  limitation.
                  50
                                                              The  partial  airway  responsiveness  to  therapy  in  COPD
         Medications                                          results in a clinical overlap between COPD, asthma and
         A number of non-ventilatory strategies may form part of   chronic  bronchitis.  A  non-proportional  Venn  diagram
         the  treatment  of  patients  with  ARDS.  Neuromuscular   (see Figure 14.2), originally used by the American Tho-
                                                                         59
         blocking  agents  (NMBAs)  are  used  to  promote     racic Society  and now in the Australian and New Zealand
   382   383   384   385   386   387   388   389   390   391   392